Back

Cardiotoxicity of immune checkpoint inhibitors: challenges in risk stratification, diagnosis, and treatment

20 March 2026 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: When the pericardium strikes back: malignancy, infection, and complications leading to tamponade Clinical ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Miss Alessandra Roccabruna

Santa Maria della Misericordia Hospital, Rovigo (Italy)

3 More presentations in this session

Presentation thumbnail
Purulent pericarditis and esophageal fistula following atrial fibrillation ablation: a life-threatening but treatable complication
Mrs A. Feu Masdemont (Girona, ES)
Slides Video
Presentation thumbnail
Unexpected culprit: cardiac tamponade following ingestion of a metallic foreign body
Doctor A. Breazu (Bucharest, RO)
Slides Video
Presentation thumbnail
Purulent pericarditis without a clear infectious source: diagnostic challenge and successful image-guided non-surgical management
Doctor P. Monteiro (Porto, PT)
Slides Video

Access the full session

Session thumbnail
When the pericardium strikes back: malignancy, infection, and complications leading to tamponade

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March 2026 14:30 CET
You may be interested in
thumbnail
Congress Session
Immune checkpoint inhibitors and the heart
thumbnail
Congress Presentation
When the heart is affected while fighting cancer: immune checkpoint inhibitor–associated myocarditis
thumbnail
Congress Presentation
Immune checkpoint inhibitor-associated myocarditis in a patient with stage IIIB squamous cell carcinoma of the lung

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources